<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Novelix Pharmaceuticals Ltd has confirmed that it does not qualify as a 'Large Corporate' (LC) entity under the SEBI framework for the financial year 2025-2026. This disclosure was made in response to a BSE query, with the company reporting zero outstanding borrowings as of March 31, 2025. This classification means the company is not subject to the additional compliance obligations applicable to Large Corporates.